UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (4494) 4494
life sciences & biomedicine (4377) 4377
animals (3793) 3793
male (2865) 2865
neurosciences & neurology (2799) 2799
neurosciences (2535) 2535
humans (2371) 2371
rats (2112) 2112
excitatory amino acid antagonists - therapeutic use (2060) 2060
excitatory amino acid antagonists - pharmacology (2017) 2017
pharmacology & pharmacy (1617) 1617
female (1236) 1236
psychiatry (1173) 1173
rats, sprague-dawley (1089) 1089
glutamate (1034) 1034
receptors, n-methyl-d-aspartate - antagonists & inhibitors (995) 995
mice (981) 981
dose-response relationship, drug (905) 905
clinical neurology (816) 816
disease models, animal (804) 804
neurology (624) 624
methyl aspartate (604) 604
neurons - drug effects (577) 577
rats, wistar (564) 564
adult (526) 526
receptors, n-methyl-d-aspartate - metabolism (517) 517
memantine - therapeutic use (495) 495
excitatory amino acid antagonists - administration & dosage (487) 487
excitatory amino acid agonists - pharmacology (475) 475
middle aged (470) 470
glutamic acid - metabolism (466) 466
time factors (465) 465
treatment outcome (462) 462
dizocilpine maleate - pharmacology (440) 440
nervous system (439) 439
rodents (433) 433
ketamine (420) 420
schizophrenia (417) 417
analysis (407) 407
neurons (386) 386
biomedicine (370) 370
cells, cultured (365) 365
in vitro techniques (365) 365
brain (358) 358
aged (347) 347
brain - drug effects (339) 339
ketamine - therapeutic use (339) 339
hippocampus - drug effects (336) 336
memantine (336) 336
mice, inbred c57bl (334) 334
neuroprotective agents - therapeutic use (334) 334
motor activity - drug effects (328) 328
analysis of variance (326) 326
biochemistry & molecular biology (322) 322
behavior, animal - drug effects (321) 321
neuroprotective agents - pharmacology (318) 318
double-blind method (315) 315
excitatory amino acid antagonists - adverse effects (315) 315
pharmacology/toxicology (308) 308
neurons - metabolism (307) 307
excitatory postsynaptic potentials - drug effects (302) 302
ketamine - pharmacology (293) 293
alzheimer disease - drug therapy (289) 289
research (287) 287
brain - metabolism (284) 284
synaptic transmission - drug effects (277) 277
receptors, n-methyl-d-aspartate - physiology (268) 268
neuroprotection (267) 267
drug therapy (266) 266
physiological aspects (265) 265
drug interactions (261) 261
nmda (261) 261
patch-clamp techniques (251) 251
hippocampus (250) 250
animals, newborn (245) 245
glutamic acid receptors (244) 244
nmda receptor (244) 244
alzheimer's disease (238) 238
neurons - physiology (231) 231
excitotoxicity (226) 226
abridged index medicus (224) 224
amino acids (224) 224
original (221) 221
receptors, metabotropic glutamate - antagonists & inhibitors (221) 221
pharmacology (215) 215
memantine - pharmacology (209) 209
hippocampus - metabolism (207) 207
n-methylaspartate - pharmacology (203) 203
receptors, n-methyl-d-aspartate - drug effects (202) 202
physiology (200) 200
synaptic transmission - physiology (199) 199
care and treatment (190) 190
receptors, metabotropic glutamate - metabolism (190) 190
gaba (187) 187
health aspects (187) 187
antidepressants (185) 185
drug therapy, combination (184) 184
n-methyl-d-aspartic acid receptors (180) 180
calcium - metabolism (179) 179
excitatory postsynaptic potentials - physiology (178) 178
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5298) 5298
German (48) 48
French (31) 31
Russian (29) 29
Spanish (29) 29
Japanese (26) 26
Chinese (9) 9
Polish (7) 7
Danish (4) 4
Dutch (3) 3
Hungarian (3) 3
Italian (3) 3
Bulgarian (2) 2
Finnish (2) 2
Hebrew (2) 2
Portuguese (2) 2
Serbian (2) 2
Ukrainian (2) 2
Lithuanian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1997, ISBN 0125468202, 171
.... Excitatory amino acid receptor agonists and antagonists are therefore of major interest as potential drugs for central nervous system disorders... 
Excitatory amino acids | Methyl aspartate | Receptors | Pathophysiology
eBook
Supportive care in cancer, ISSN 1433-7339, 05/2010, Volume 19, Issue 6, pp. 833 - 841
Chemotherapy-induced peripheral neuropathy (CIPN) is a troublesome chronic symptom that has no proven pharmacologic treatment. The purpose of this double-blind... 
Pain Medicine | Rehabilitation Medicine | Nursing | Medicine & Public Health | Topical gel | Oncology | CIPN | BAK-PLO | Nursing Management/Nursing Research | Health Care Sciences & Services | Rehabilitation | Life Sciences & Biomedicine | Science & Technology | Excitatory Amino Acid Antagonists - therapeutic use | Peripheral Nervous System Diseases - chemically induced | GABA-B Receptor Agonists - therapeutic use | Humans | Middle Aged | Male | GABA-B Receptor Agonists - adverse effects | Administration, Cutaneous | GABA-B Receptor Agonists - administration & dosage | Ketamine - administration & dosage | Baclofen - adverse effects | Ketamine - adverse effects | Lecithins - chemistry | Antineoplastic Agents - adverse effects | Female | Ketamine - therapeutic use | Excitatory Amino Acid Antagonists - adverse effects | Baclofen - therapeutic use | Poloxamer - chemistry | Adrenergic Uptake Inhibitors - adverse effects | Adrenergic Uptake Inhibitors - therapeutic use | Double-Blind Method | Gels | Baclofen - administration & dosage | Excitatory Amino Acid Antagonists - administration & dosage | Treatment Outcome | Amitriptyline - adverse effects | Adrenergic Uptake Inhibitors - administration & dosage | Aged | Amitriptyline - therapeutic use | Drug Combinations | Peripheral Nervous System Diseases - drug therapy | Amitriptyline - administration & dosage | Amitriptyline | Chemotherapy | Lecithin | Baclofen | Clinical trials | Research | Cancer | Side effects | Drug therapy | Neurological disorders | Index Medicus
Journal Article
CNS & neurological disorders drug targets, ISSN 1871-5273, 12/2009, Volume 8, Issue 6, pp. 475 - 491
Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor symptoms including tremor and bradykinesia. The primary pathophysiology... 
AMPA receptor | Basal ganglia | Parkinson's disease | Neurodegeneration |